Physical AI · Sterile fill-finish autonomy

Every dose,
perfectly sterile.

Sterira is the autonomous operations layer for sterile pharmaceutical fill-finish. It runs aseptic filling, seal & container-closure integrity, lyophilization, AI visual inspection, contamination control, robotic handling, and batch review, all inside your validated envelope.

Validated for
Annex 1 · 21 CFR Part 11 · GAMP 5
Deploys at
The isolator edge
GRADE A ISOLATOR · LINE 03AUTONOMOUS
Fill accuracy0%
Viable count0 CFU
CCISEALED
Rejects0%
0%false rejects on AI visual inspection
fewer aseptic-intervention deviations
0%shorter lyophilization cycle time
0%net revenue retention, land-and-expand

The formats, isolators, and standards you already run.

VIALS
PREFILLED SYRINGES
CARTRIDGES
LYOPHILIZED
GRADE A ISOLATOR
RABS
EU GMP ANNEX 1
21 CFR PART 11
GAMP 5
OPC UA / MES

The problem

Fill-finish is a black art run at the edge of physics and biology.

Sterile injectables go straight into the bloodstream, so one viable microbe, a stray glass particle, or a hairline seal breach can harm a patient and halt a line.

  • Fill weights must hit micro-tolerances on shear-sensitive biologics without foaming.
  • Lyo cycles span days where one wrong ramp collapses the cake or ruins potency.
  • Every gowned intervention is a contamination risk a failed media fill can shut down.
  • The aseptic experts who govern release are a scarce, aging craft.
#1
cause of FDA 483 observations: deviations and human-borne contamination
100%
of units must pass inspection before a batch can ship
$1M+
per batch, where a single false reject scraps good product
~15%
annual growth in sterile capacity demand, against a shrinking expert pool

Seven agents and a digital twin for the whole suite.

Sterira closes the loop from perception to line-and-isolator control across every stage of fill-finish. Select a stage.

Fill-and-dose agent

Controls fill weight and volume, pump and peristaltic parameters, foaming, and in-process weight checks.

    Aseptic-line & lyo digital twin

    Hit the target spec before the batch.

    Sterira simulates filling, the lyophilization cycle, and contamination flow across the isolator, so the line converges on spec in silico before a single vial is filled.

    Explore the digital twin
    LYO CYCLE · SIMULATIONCONVERGED
    Target envelopeOptimized cycle

    A closed loop, from perception to control.

    Sterira doesn't just observe. It acts on the line, inside your validated envelope, with a Part 11 audit trail on every decision.

    1. Perceive

      See every vial

      Edge perception fuses fill weight, particulate, CCI, and lyo state at line speed.

    2. Reason

      Predict & decide

      Physics-informed models reason against validated control envelopes and the twin.

    3. Act

      Control the line

      Agents adjust fill, seal, lyo, inspection, and handling: grounded and reversible.

    4. Compound

      Learn per batch

      Every outcome feeds the data flywheel, tightening the envelope with each release.

    Built for release

    Validation is the product, not an afterthought.

    Sterira is architected for GMP, GAMP 5, 21 CFR Part 11 data integrity, and EU GMP Annex 1's contamination-control strategy, with grounded, auditable outputs at every step.

    EU GMP Annex 121 CFR Part 11GAMP 5Grade A / RABSAudit trail by design
    See our validation approach

    Grounded & auditable

    Every decision traces to a signal and a rule, with a Part 11 audit trail.

    Deep integration

    Connects to filling, isolator/RABS, lyo, and inspection systems plus MES over API/OPC.

    Edge deployment

    Low-latency perception and control run at the isolator edge.

    Reversible by design

    Actions stay within validated envelopes and can be reviewed and rolled back.

    "We stopped scrapping good, million-dollar units. Sterira's inspection agent cut our false rejects by more than half in the first quarter, and QA finally trusts the release trail."
    DRDirector of Sterile Manufacturing
    Top-10 CDMO · design partner

    Land one line. Expand the suite.

    Recurring SaaS with a line + site + outcome hybrid. Start on a paid pilot with a hard reject, deviation, or yield metric.

    Line

    $14k/ line / mo

    One process agent on a single fill or inspection line.

    • Edge perception & control
    • Part 11 audit trail
    • Defined-metric pilot
    See details

    Enterprise

    Custom$0.7-8M ACV

    Multi-site autonomy with custom models and a validated edge fleet.

    • Multi-site & custom models
    • Validation support & SLAs
    • Dedicated team
    See details

    What manufacturers ask first.

    Yes, within validated control envelopes and with a Part 11 audit trail. Every action is grounded in a signal and a rule, is reviewable, and is reversible. You choose the autonomy level per workflow, from advisory to closed-loop control.

    Sterira connects to filling machines, isolator/RABS, lyophilizers, and inspection systems plus MES over API and OPC UA. Integrations are read-first, then graduate to control as validation is established. See the integrations page.

    We land with a single high-ROI workflow on a paid pilot, measured on a hard reject, deviation, or yield metric. Once proven, you expand line-by-line and site-by-site.

    Sterira is architected for GMP, GAMP 5, 21 CFR Part 11, and EU GMP Annex 1. We provide validation support and documentation for regulated deployments. See validation.

    Run the fill-finish suite autonomously.

    Land with a single high-ROI workflow on a paid pilot, measured on a hard reject, deviation, or yield metric. Then expand line-by-line and site-by-site.

    For CDMOs and pharma/biotech manufacturers running aseptic fill-finish.